— Know what they know.
Not Investment Advice

LIVN NASDAQ

LivaNova PLC
1W: +2.8% 1M: +13.0% 3M: +7.6% YTD: +21.4% 1Y: +64.1% 3Y: +57.5% 5Y: -12.4%
$73.83
+0.19 (+0.26%)
 
Weekly Expected Move ±9.7%
$56 $63 $70 $77 $84
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Buy · Power 72 · $4.1B mcap · 55M float · 1.62% daily turnover · Short 60% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$1.4B +10.7% ▲
5Y CAGR: +8.2%
Gross Profit
$940M +7.9% ▲
5Y CAGR: +9.6%
Operating Income
$199M +54.5% ▲
Net Income
-$242M -483.5% ▼
EPS (Diluted)
$-4.45 -483.6% ▼
EBITDA
-$130M -163.9% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.0B$1.0B$1.2B$1.3B$1.4B
YoY Growth+10.8%-1.3%+12.9%+8.7%+10.7%
Cost of Revenue$329M$315M$382M$383M$448M
Gross Profit$706M$707M$771M$871M$940M
Gross Margin68.2%69.2%66.9%69.5%67.7%
R&D Expenses$183M$156M$194M$183M$186M
SG&A Expenses$472M$469M$518M$526M$549M
Operating Expenses$707M$784M$840M$742M$740M
Operating Income-$784K-$77M-$68M$129M$199M
Operating Margin-0.1%-7.5%-5.9%10.3%14.4%
Interest Expense$50M$48M$59M$63M$49M
Income Before Tax-$125M-$75M-$81M$88M-$221M
Tax Expense$11M$11M-$99M$25M$22M
Net Income-$136M-$86M$18M$63M-$242M
Net Margin-13.1%-8.4%1.5%5.0%-17.5%
EPS (Diluted)$-2.68$-1.61$0.32$1.16$-4.45
EBITDA-$6M$31M$38M$203M-$130M
Shares Outstanding51M54M54M55M54M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms